{"id":2113,"date":"2026-01-23T17:24:04","date_gmt":"2026-01-23T17:24:04","guid":{"rendered":"https:\/\/www.fsf-dev.org\/public\/?page_id=2113"},"modified":"2026-01-23T18:07:50","modified_gmt":"2026-01-23T18:07:50","slug":"funding-opportunities-archive","status":"publish","type":"page","link":"https:\/\/www.fsf-dev.org\/public\/updates\/funding-opportunities\/funding-opportunities-archive\/","title":{"rendered":"Funding Opportunities Archive"},"content":{"rendered":"\n
\n

Funding Opportunities Archive<\/h2><\/div>\n<\/div>\n\n\n\n

\u27f5Back to Funding Opportunities<\/a><\/p>\n\n\n\n

\n

NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

PAR-24-274<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

September 16, 2024<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

November 4, 2024<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/PAR-24-274.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in partnership with Pelotonia & AACR<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

N\/A<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

March 26, 2024<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

May 15, 2024<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/www.lungevity.org\/research\/translational-science-research-award-programs\/applying-for-lungevity-research-award<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Winn Career Development Award (Winn CDA)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

N\/A<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

March 26, 2024<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

May 13, 2024<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/winnawards.smapply.io<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Cancer Immunoprevention Network (CIP-Net) .Research Projects (UG3\/UH3 Clinical Trials Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-23-029<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

April 20, 2023<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

July 3, 2023<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-23-029.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

N\/A<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

January 30, 2023<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

February 28, 2023<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-OD-23-029.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-23-020<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

November 17, 2022<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

March 01, 2023<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-23-020.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-23-021<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

November 17, 2022<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

March 01, 2023<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-23-021.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-23-022<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

November 17, 2022<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

March 01, 2023<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-23-022.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-22-050<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

September 1, 2022<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

Various<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-22-050.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

NOT-OD-22-057<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

February 4, 2022<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

April 7, 2022<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-OD-22-057.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Chan Zuckerberg Initiative – Science Diversity Leadership Award<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

N\/A<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

January 26, 2022<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

May 19, 2022<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/czi-sciencediversityleadership.nas.edu<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Coordinating Center for HIV\/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (U24 Clinical Trial Required)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-21-045<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

October 26, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

December 28, 2021<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-21-045.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Research Bases for HIV\/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (UG1 Clinical Trial Required)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-21-046<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

October 26, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

December 28, 2021<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-21-046.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Clinical Sites for HIV\/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (UG1 Clinical Trial Required)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-21-047<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

October 26, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

December 28, 2021<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-21-047.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

PAR-21-330<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

September 9, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

Various (see FOA for details)<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/PAR-21-330.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

PAR-21-306<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

August 20, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

Various (see FOA for details)<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/PAR-21-306.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

PAR-21-286<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

July 23, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

November 1, 2021<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/par-21-286.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

PAR-21-285<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

July 21, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

November 1, 2021<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/PAR-21-285.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-21-039<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

July 15, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

October 7, 2021<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-21-039.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

RFA-CA-21-038<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

July 15, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

October 7, 2021<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-21-038.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Notice of Special Interest: National Cancer Institute Administrative Supplement Opportunity for Strategies to Optimize Recruitment and Retention of Cancer Prevention and Symptom Management Clinical Trial Participants<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

NOT-CA-21-070<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

April 27, 2021<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

Various (see FOA for details)<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-CA-21-070.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

PA-21-071<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

November 16, 2020<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

Due dates vary by awarding IC<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/PA-21-071.html<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n

NIH Planning Grant Program (R34)<\/h3>\n\n\n\n
\n
\n

ID:<\/p>\n\n\n\n

Various<\/p>\n<\/div>\n\n\n\n

\n

Posted Date:<\/p>\n\n\n\n

February 27, 2019<\/p>\n<\/div>\n\n\n\n

\n

Submission Due:<\/p>\n\n\n\n

Various<\/p>\n<\/div>\n\n\n\n

\n

More Information:<\/p>\n\n\n\n

https:\/\/grants.nih.gov\/grants\/funding\/r34.htm<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u27f5Back to Funding Opportunities NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) ID: PAR-24-274 Posted Date: September 16, 2024 Submission Due: November 4, 2024 More Information: https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/PAR-24-274.html Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in partnership with Pelotonia & AACR ID: N\/A Posted Date: March 26, 2024 Submission Due: […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":26,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2113","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/pages\/2113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/comments?post=2113"}],"version-history":[{"count":6,"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/pages\/2113\/revisions"}],"predecessor-version":[{"id":2124,"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/pages\/2113\/revisions\/2124"}],"up":[{"embeddable":true,"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/pages\/26"}],"wp:attachment":[{"href":"https:\/\/www.fsf-dev.org\/public\/wp-json\/wp\/v2\/media?parent=2113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}